G1 Therapeutics
GTHX
#7242
Rank
โ‚ฌ0.35 B
Marketcap
6,81ย โ‚ฌ
Share price
0.00%
Change (1 day)
195.59%
Change (1 year)

Revenue for G1 Therapeutics (GTHX)

Revenue in 2024 (TTM): โ‚ฌ53.91 Million

According to G1 Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ55.42 Million. In 2023 the company made a revenue of โ‚ฌ74.63 Million an increase over the revenue in the year 2022 that were of โ‚ฌ47.82 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for G1 Therapeutics from 2016 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ53.91 M-27.77%
2023 โ‚ฌ74.63 M56.07%
2022 โ‚ฌ47.82 M72.08%
2021 โ‚ฌ27.79 M-24.51%
2020 โ‚ฌ36.81 M
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA